esi lamouse-smith – CYBER ERA: Catalyzing the Digital Economy

J&J’s Oral IL-23 Peptide Icotrokinra Delivers In UC After Psoriasis Triumph

admin2 years agoMarch 20, 2025

275

By Anna Bratulic Johnson & Johnson's icotrokinra met the primary endpoint of a Phase IIb ulcerative colitis (UC) study, building...

admin2 years agoMarch 13, 2025

211

By Anna Bratulic Johnson & Johnson's icotrokinra met the primary endpoint of a Phase IIb ulcerative colitis (UC) study, building...